During the past decade, Nishiarai Heart Central Clinic conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Nishiarai Heart Central Clinic" are "Atrial Fibrillation (AF)" (1 trials) and "Heart Failure" (1 trials). Many other conditions were trialed in "Nishiarai Heart Central Clinic" in a lesser frequency.

Most popular intervention types in "Nishiarai Heart Central Clinic" are "Drug" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials), "BAY2433334" (1 trials), "BAY2433334 matching placebo" (1 trials) and "Finerenone (BAY94-8862)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nishiarai Heart Central Clinic" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Nishiarai Heart Central Clinic". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Nishiarai Heart Central Clinic, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Nishiarai Heart Central Clinic, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".